CLDX compared with VRDN: revenue, margins and what each company keeps, and the suppliers and customers both name

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

VRDNViridian Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CLDXCelldex Therapeutics, Inc.

VRDNViridian Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CLDX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±9.0%▲+5.66%×0.63

Q2 FY26±9.8%▲+0.36%×0.04

May 8 '26±7.6%▲+1.95%×0.25

Q1 FY26±13.6%▼−0.58%×0.04

VRDN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±16.7%▲+15.53%×0.93

Q2 FY26±17.2%▲+6.83%×0.40

= impliedCLDX realized, solidVRDN realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedSource: market data

May 5 '26

±9.5%

▲+33.36%

×3.52

Q1 FY26±24.8%▲+1.90%×0.08

CLDXCelldex Therapeutics, Inc.

29.87▲+5.66%· post 29.87

Mkt cap$2.3BRevenue$22,000Q2 FY26Revenue$7MFY24

VRDNViridian Therapeutics, Inc.

28.49▼−0.23%· post 28.97

ClosedNov 6 '26

Mkt cap$3.2BRevenue$26MQ3 FY26Revenue$71MFY25

Compare

ClosedNov 6 '26

CLDXCelldex Therapeutics, Inc.

VRDNViridian Therapeutics, Inc.

29.87▲+5.66%post 29.87

Price

28.49▼−0.23%post 28.97

$2.3B

Mkt cap

$3.2B

Q2 FY26$22,000

Revenue

$26MQ3 FY26

FY24$7M

Revenue

$71MFY25

CLDX29.87▲+5.66%vsVRDN28.49▼−0.23%ClosedNov 6 '26